Clarifying SABA overuse: Translating Canadian Thoracic Society guidelines into clinical practice

Abstract Patients with asthma frequently over rely on short-acting beta-agonists (SABA) to treat acute symptoms. This can adversely impact quality of life and increase the risk of exacerbations. SABA overuse is also associated with an increased risk of mortality. In their 2021 update on the diagnosi...

Full description

Bibliographic Details

Published in:	Allergy, Asthma & Clinical Immunology
Main Authors:	Anne K. Ellis, Vanessa Foran, Alan Kaplan, Patrick D. Mitchell
Format:	Article
Language:	English
Published:	BMC 2022-06-01
Subjects:	Asthma Controlled Rescue Short-acting beta agonist Overreliance Overuse
Online Access:	https://doi.org/10.1186/s13223-022-00690-2